We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+3.55%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$53.2B
AUM Growth
+$186M
(+0.35%)
Cap. Flow
-$2.09B
Cap. Flow
% of AUM
-3.93%
Top 10 Holdings %
Top 10 Hldgs %
22.43%
Holding
1,084
New
91
Increased
297
Reduced
370
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$572M |
| 2 |
Medtronic
MDT
|
+$566M |
| 3 |
K
Kellanova
K
|
+$336M |
| 4 |
Citigroup
C
|
+$316M |
| 5 |
Molson Coors Class B
TAP
|
+$288M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$431M |
| 2 |
Pfizer
PFE
|
+$415M |
| 3 |
CSX Corp
CSX
|
+$331M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$263M |
| 5 |
Aptiv
APTV
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 14.81% |
| 2 | Technology | 13.9% |
| 3 | Industrials | 13.71% |
| 4 | Healthcare | 12.82% |
| 5 | Financials | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
AbbVie
ABBV
$458B
| $23.9M | 0.04% |
329,202
+32,062
| +11% | +$2.16M |
|
252
Campbell Soup
CPB
$6.51B
| $23.8M | 0.04% |
456,954
+255,481
| +127% | +$14.5M |
|
253
Texas Instruments
TXN
$255B
| $23.8M | 0.04% |
308,962
-170,178
| -36% | -$13.6M |
|
254
M&T Bank
MTB
$36.2B
| $23.3M | 0.04% |
144,021
-45,846
| -24% | -$7.23M |
|
255
Cigna
CI
$76.6B
| $23M | 0.04% |
137,123
+111,390
| +433% | +$17.9M |
|
|
ABE
256
DELISTED
Aberdeen Emerging Markets Smaller Company Opportunities Fund
ABE
| $22.9M | 0.04% |
1,658,641
+4,500
| +0.3% | +$61.8K |
|
257
Amgen
AMGN
$203B
| $22.6M | 0.04% |
131,363
-77,496
| -37% | -$12.6M |
|
258
Ternium
TX
$9.29B
| $22.4M | 0.04% |
797,155
-15,931
| -2% | -$407K |
|
|
BHI
259
DELISTED
Baker Hughes
BHI
| $22.4M | 0.04% |
410,597
-111,910
| -21% | -$6.43M |
|
260
Carnival Corporation Ltd
CCL
$36.1B
| $22.2M | 0.04% |
338,867
+34,396
| +11% | +$2.14M |
|
261
US Bancorp
USB
$99.6B
| $22M | 0.04% |
424,603
-134,948
| -24% | -$6.95M |
|
262
Extra Space Storage
EXR
$31.2B
| $22M | 0.04% |
281,937
+15,694
| +6% | +$1.2M |
|
|
EGRX
263
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $22M | 0.04% |
278,282
+254,007
| +1,046% | +$20.8M |
|
264
American Tower
AMT
$77.7B
| $21.9M | 0.04% |
165,410
-9,752
| -6% | -$1.25M |
|
265
Truist Financial
TFC
$63.2B
| $21.3M | 0.04% |
469,093
-149,106
| -24% | -$6.47M |
|
266
Walmart Inc
WMT
$871B
| $21.2M | 0.04% |
840,249
+115,041
| +16% | +$2.92M |
|
|
LAQ
267
DELISTED
Aberdeen Latin America Equity Fund
LAQ
| $20.8M | 0.04% |
897,887
-9,322
| -1% | -$220K |
|
|
TWX
268
DELISTED
Time Warner Inc
TWX
| $20.8M | 0.04% |
206,852
-85,573
| -29% | -$8.47M |
|
269
Idexx Laboratories
IDXX
$42.9B
| $20.5M | 0.04% |
126,730
+38,608
| +44% | +$6.27M |
|
270
AES
AES
$10.6B
| $20.4M | 0.04% |
1,833,779
-306,282
| -14% | -$3.52M |
|
271
Abbott
ABT
$180B
| $20.1M | 0.04% |
412,998
-129,714
| -24% | -$5.87M |
|
|
CTRA
272
DELISTED
Coterra Energy
CTRA
| $20M | 0.04% |
797,997
-232,389
| -23% | -$5.49M |
|
273
Adobe
ADBE
$89.5B
| $19.8M | 0.04% |
139,852
+33,343
| +31% | +$4.57M |
|
274
General Mills
GIS
$19.2B
| $19.5M | 0.04% |
351,626
-184,426
| -34% | -$10.5M |
|
|
NBL
275
DELISTED
Noble Energy, Inc.
NBL
| $19.4M | 0.04% |
686,812
-218,379
| -24% | -$6.8M |
|
Similar funds
QCM
Lazard Asset Management's Q2 2017 Portfolio in Review
As of Q2 2017, Lazard Asset Management held 1,084 positions worth $53.2B, up 0.35% from $53B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Lazard Asset Management withdrew a net $2.09B in Q2 2017, closing 78 positions and reducing 370 holdings. Its most notable exit was KeyCorp, an estimated $52.8M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 15% of assets, down from 15% a quarter earlier, followed by Technology and Industrials.
Against the trend, Lazard Asset Management opened a new position in DXC Technology worth $572M.
- Lazard Asset Management's largest Q2 2017 buy was DXC Technology: 8,613,465 shares worth $572M.
- Lazard Asset Management added most to Medtronic in Q2 2017, an estimated $566M increase.
- Lazard Asset Management's biggest Q2 2017 reduction was Bank of America, cutting an estimated $431M.
- Lazard Asset Management fully exited KeyCorp in Q2 2017, selling an estimated $52.8M.
- Lazard Asset Management's ten largest holdings make up 22% of its $53.2B portfolio in Q2 2017.
- Lazard Asset Management opened 91 new positions and closed 78 in Q2 2017.
- Lazard Asset Management's portfolio value rose 0.35% quarter-over-quarter to $53.2B.
Based on Lazard Asset Management's 13F filing for Q2 2017, filed 11 Aug 2017.